Raymond C. Bergan

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Julie N. Graff, Joshi J. Alumkal, Charles G. Drake et al. · Oncotarget · 2016 · 360 citations · Full text

Medicine, Oncology, Pharmacology +8

Circulating giant macrophages as a potential biomarker of solid tumors

Daniel L. Adams, Stuart S. Martin, R. Katherine Alpaugh et al. · Proceedings of the National Academy of Sciences · 2014 · 279 citations · Full text

Medicine, Cancer Biology, Oncology +17

MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer

Li Xu, S Chen, Raymond C. Bergan · Oncogene · 2005 · 215 citations

Medicine, Cell Biology, Oncology +14

Genistein Inhibits p38 Map Kinase Activation, Matrix Metalloproteinase Type 2, and Cell Invasion in Human Prostate Epithelial Cells

Xiaoke Huang, Shan Chen, Li Xu et al. · Cancer Research · 2005 · 213 citations

Medicine, Oncology, Pharmacology +15

Genistein-Induced Apoptosis of Prostate Cancer Cells is Preceded by a Specific Decrease in Focal Adhesion Kinase Activity

Edward Kyle, Len Neckers, Chris H. Takimoto et al. · Molecular Pharmacology · 1997 · 183 citations

Medicine, Oncology, Pharmacology +8